Почетна › Рак на бели дробови › Масачусетс
Клинички испитувања за Рак на бели дробови во Масачусетс
75 студии за Рак на бели дробови бараат учесници на локации во Масачусетс.
Градови во Масачусетс
- Boston62 студии
- Worcester11 студии
- Somerville6 студии
- Springfield5 студии
- Lynn3 студии
- Lawrence3 студии
- Quincy3 студии
- Newton3 студии
Официјален текст на студијата (англиски)
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
- Tufts Medical Center, Boston
- Dana-Farber Cancer Institute at Boston Medical Center - Brighton, Brighton
- Dana-Farber Cancer Institute at Foxborough, Foxborough
- и уште 3
Се регрутираФаза 3
Возраст 70 и постари · Сите полови · Ажурирано 5.10.2026 · NCT06096844Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- Beverly Hospital, Beverly
- Boston Medical Center, Boston
- Beth Israel Deaconess Medical Center, Boston
- и уште 8
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT04267848Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
- UMass Memorial Medical Center - University Campus, Worcester
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT04181060The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Се регрутираФаза 1/2
Возраст 12 и постари · Сите полови · Ажурирано 2.10.2026 · NCT04585750Distance-Based Exercise to Preserve Function and Prevent Disability
- Dana-Farber Cancer Institute, Boston
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT07059884Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- Beverly Hospital, Beverly
- Lahey Clinic, Burlington
- Addison Gilbert Hospital, Gloucester
- и уште 3
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT06498635Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Insitute, Boston
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT06625775Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
- Dana-Farber Cancer Institute, Boston
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 30.9.2026 · NCT06765109A Study of PHN-012 in Patients With Advanced Solid Tumors
- PHN-012-001 Site, Boston
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 29.9.2026 · NCT07127874A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Reliant Medical Group Inc, Worcester
Се регрутираФаза 3
Возраст од 18 до 100 · Сите полови · Ажурирано 25.9.2026 · NCT05920356This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
- Southcoast Centers for Cancer Care, Fairhaven
- Southcoast Centers for Cancer Care, Fall River
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06758401A Registry for People With Lung Cancer
- Massachusetts General Hospital Cancer Center (Data Collection Only), Boston
- Brigham and Women's Hospital (Data Collection Only), Boston
Се регрутираНабљудувачка студија
Возраст 18 и постари · Сите полови · Ажурирано 24.9.2026 · NCT06424327Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
- Research Site, Boston
Се регрутираФаза 2
Возраст од 18 до 95 · Сите полови · Ажурирано 23.9.2026 · NCT05061550A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
- Dana-Farber Cancer Institute, Boston
Се регрутираФаза 2/3
Возраст 18 и постари · Сите полови · Ажурирано 23.9.2026 · NCT07063745A Community Health Intervention to Improve Lung Cancer Screening Uptake in Community Health Centers
- Baystate Health, Springfield
Се регрутираДобредојдени се здрави волонтери
Возраст од 50 до 80 · Сите полови · Ажурирано 22.9.2026 · NCT07168629Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
- Dana-Farber Cancer Institute, Boston
Се регрутираФаза 2/3
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07100080Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Dana Farber Cancer Institute, Boston
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT06128551A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
- Massachusetts General Hospital - Main Campus, Boston
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 21.9.2026 · NCT07629960Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
- Dana-Farber Cancer Institute, Boston
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 17.9.2026 · NCT07349537Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Dana-Farber Cancer Institute, Boston
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 16.9.2026 · NCT05786924Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- Dana Farber Cancer Institute, Boston
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 10.9.2026 · NCT06293898Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 9.9.2026 · NCT04899908A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 8.9.2026 · NCT06561685A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Boston Medical Center, Boston
- Lahey Hospital & Medical Center, Burlington
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 8.9.2026 · NCT06119581A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
- Massachusetts General Hospital, Boston
- University of Massachusetts Memorial Medical Center, Worcester
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 8.9.2026 · NCT06793215AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Avenzo Therapeutics Recruiting Site, Boston
Се регрутираФаза 1/2
Возраст од 18 до 75 · Сите полови · Ажурирано 4.9.2026 · NCT07038343Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
- Beth Israel Lahey Health - Lahey Hospital & Medical Center (LHMC), Lahey Clinic Medical Center, Burlington
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 1.9.2026 · NCT06712355Investigating Hereditary Risk In Thoracic Cancers (INHERIT)
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Се регрутираНабљудувачка студија
Возраст 18 и постари · Сите полови · Ажурирано 26.8.2026 · NCT05587439LEGACY: Lung Cancer Screening in Individuals With a Lung Cancer Family History-Protocol B
- Massachusetts General Hospital, Boston
Се регрутираНабљудувачка студија
Возраст 18 и постари · Сите полови · Ажурирано 25.8.2026 · NCT07600801Practical Geriatric Assessment in Older Adults With Non-Small Cell Lung Cancer Undergoing Stereotactic Body Radiation Therapy
- Brigham and Women's Hospital, Boston
Се регрутира
Возраст 65 и постари · Сите полови · Ажурирано 25.8.2026 · NCT06987890InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
- Dana Farber Cancer Institute, Boston
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
Сите возрасти · Сите полови · Ажурирано 17.8.2026 · NCT05463796Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
- UMass Memorial Medical Center - University Campus, Worcester
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 17.8.2026 · NCT05624996A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- Massachusetts General Hospital Cancer Center, Boston
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 11.8.2026 · NCT05592626Preliminary Efficacy of Different Exercise Training During Immunotherapy in Patients With Lung Cancer: The ENHANCE Trial
- Dana-Farber Cancer Institute, Boston
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 10.8.2026 · NCT06026111Precise Exercise Regimen for Cancer Care (PERCC): A Pilot Study
- Dana-Farber Cancer Institute, Boston
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 5.8.2026 · NCT07412041Ivonescimab Alone And With Carboplatin/Pemetrexed For NSCLC
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
- Dana-Farber Cancer Institute, Boston
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 15.7.2026 · NCT07405190EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations
- Beth Israel Deaconess Medical Center, Boston
- Dana-Farber Cancer Institute, Boston
- Massachusetts General Hospital, Boston
- и уште 3
Се регрутираДобредојдени се здрави волонтери
Возраст од 40 до 80 · Сите полови · Ажурирано 15.7.2026 · NCT06716580A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 15.7.2026 · NCT05652686Mobile Application to Improve Health-Related Outcomes in Patients With Advanced Lung Cancer
- Massachusetts General Hospital, Boston
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 13.7.2026 · NCT06427954Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
- Massachusetts General Hospital, Boston
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 9.7.2026 · NCT07315113Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.